CHIC 2026 Honors Top Healthcare Deals and Financings at Annual Awards Gala

miércoles, 1 de abril de 2026, 9:37 pm ET1 min de lectura
GSK--
VOR--

The 12th Annual China Healthcare Investment Conference (CHIC 2026) recognized outstanding achievements in healthcare investment, financing, and deal-making over the past year. Award winners included Insilico Medicine for IPO of the Year, Kailera Therapeutics and Vor Bio for Private Financing of the Year, and Hengrui Pharma-GSK and Innovent-Takeda for Deal of the Year. The conference, held on March 23-24, brought together senior decision-makers from venture capital, private equity, and pharmaceutical industries to discuss innovation in healthcare.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios